Related Experiment Video

Updated: Apr 24, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

14.2K

Cardiac rehabilitation is associated with lasting improvements in cognitive function in older adults with heart

Michael L Alosco, Mary Beth Spitznagel, Ronald Cohen

    Acta Cardiologica
    |September 4, 2014
    PubMed

    Insights

    Cardiac rehabilitation (CR) offers acute and lasting cognitive benefits for heart failure (HF) patients. This program improved attention, executive function, and memory, with lasting effects observed up to 12 months post-intervention.

    Area of Science:

    • Cardiology
    • Neuroscience
    • Rehabilitation Medicine

    Background:

    • Heart failure (HF) is a significant risk factor for cognitive impairment.
    • Cardiac rehabilitation (CR) may improve cognitive function by enhancing physical fitness.
    • Previous research has not examined the acute and long-term cognitive effects of CR in HF patients.

    Purpose of the Study:

    • To investigate the acute and lasting effects of a 12-week cardiac rehabilitation (CR) program on cognitive function in patients with heart failure (HF).
    • To assess the impact of CR on attention, executive function, and memory in HF patients.
    • To determine if improvements in physical fitness correlate with cognitive enhancements.

    Main Methods:

    • Fifty-two HF patients participated in a 12-week Phase II CR program.
    • Neuropsychological testing and physical fitness assessments were conducted at baseline, 12 weeks, and 12-month follow-up.
    • Repeated measures analyses were used to evaluate changes in cognitive function and physical fitness over time.

    Main Results:

    • Significant improvements were observed in attention/executive function from baseline to 12 weeks, maintained up to 12 months.
    • Memory function showed no change at 12 weeks but improved significantly by the 12-month follow-up.
    • Physical fitness improved by 12 weeks and benefits were sustained at 12 months; poorer baseline fitness correlated with lower cognitive performance.

    Conclusions:

    • Cardiac rehabilitation (CR) provides both short-term and sustained cognitive benefits for individuals with heart failure (HF).
    • Further research is needed to elucidate the mechanisms (e.g., cerebral perfusion) driving cognitive improvements after CR.
    • CR may play a role in reducing the risk of cognitive decline in HF patients, potentially mitigating conditions like Alzheimer's disease.
    Abstract

    More Related Videos

    Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest07:02

    Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

    Published on: January 5, 2018

    11.7K
    Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

    Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

    Published on: December 11, 2017

    10.2K

    Related Concept Videos

    Cognitive Development During Adulthood01:30

    Cognitive Development During Adulthood

    Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
    1.4K
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    745
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    783
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    629
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    1.6K
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    801